Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 14 (1), e0210833
eCollection

Demonstration of Background Rates of Three Conditions of Interest for Vaccine Safety Surveillance

Affiliations

Demonstration of Background Rates of Three Conditions of Interest for Vaccine Safety Surveillance

Anne E Wormsbecker et al. PLoS One.

Abstract

Introduction: Adverse events following immunization (AEFIs) are unwanted or unexpected health outcomes following vaccination, which may or may not be causally-linked to vaccines. AEFI reporting is important to post-marketing vaccine safety surveillance and has the potential to identify new or rare AEFIs, show increases in known AEFIs, and help to maintain public confidence in vaccine programs. Knowledge of the expected incidence (i.e. background rate) of a possible AEFI is essential to the investigation of vaccine safety signals. We selected three rarely reported AEFIs representing the spectrum of causal association with vaccines, from proven (immune thrombocytopenia [ITP]) to questioned (Kawasaki disease [KD]) to unsubstantiated (multiple sclerosis [MS]) and determined their background rates.

Methods: We extracted data on hospitalizations (CIHI Discharge Abstract Database) for ITP, KD, and MS among Ontario children for the period 2005 to 2014 from IntelliHEALTH. As ITP can be managed without hospitalization, we also extracted emergency department (ED) visits from the CIHI National Ambulatory Care Reporting System. For all conditions, we only counted the first visit and if the same child had both an ED visit and a hospitalization for ITP, only the hospitalization was included. We calculated rates by year, age group and sex using population estimates from 2005-2014, focusing on age groups within the Ontario immunization schedule around vaccine(s) of interest.

Results: Per 100,000 population, annual age-specific incidence of ITP in children age 1 to 7 years ranged from 8.9 to 12.2 and annual incidence of KD in children less than 5 years ranged from 19.1 to 32.1. Average annualized incidence of adolescent (11-17 years) MS across the study period was 0.8 per 100,000.

Discussion: Despite limitations, including lack of clinical validation, this study provides an example of how health administrative data can be used to determine background rates which may assist with interpretation of passive vaccine safety surveillance.

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. Immune thrombocytopenia hospitalizations and emergency department visits among Ontario children age 1–7 years, by age and sex, 2005–2014.
Fig 2
Fig 2. Kawasaki disease hospitalizations among Ontario children age 0–9 years, by year, 2005–2014.
Fig 3
Fig 3. Kawasaki disease hospitalizations among Ontario children age 0–9 years, by age and sex, 2005–2014.

Similar articles

See all similar articles

References

    1. Ontario Agency for Health Protection and Promotion (Public Health Ontario). Annual report on vaccine safety in Ontario, 2014 Toronto, ON: Queen's Printer for Ontario; 2015.
    1. Black S, Eskola J, Siegrist CA, Halsey N, Macdonald N, Law B, et al. Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccines. Lancet. 2009;374: 2115–2122. 10.1016/S0140-6736(09)61877-8 - DOI - PMC - PubMed
    1. Wang Y, Wu L, Yu X, Zhao F, Russell A, Song M, et al. The expected number of background disease events during mass immunization in China. PLoS One. 2013;8: e71818 10.1371/journal.pone.0071818 - DOI - PMC - PubMed
    1. Deeks SL, Lim GH, Simpson MA, Rosella L, Mackie CO, Achonu C, et al. Estimating background rates of Guillain-Barre Syndrome in Ontario in order to respond to safety concerns during pandemic H1N1/09 immunization campaign. BMC Public Health. 2011;11: 329-2458-11-329. - PMC - PubMed
    1. Institute of Medicine (US) Vaccine Safety Committee. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. (Stratton K. R., C. J. Howe, & R. B. Johnston, Eds.) Washington, DC: The National Academies Press (US), 1994. 10.17226/2138 - DOI

MeSH terms

Grant support

The authors received no specific funding for this work.
Feedback